Pefloxacin - Current Litigation

Current Litigation

There are a significant number of cases currently pending before the United States District Court, District of Minnesota, involving one of the drugs found within the fluoroquinolone class; Levaquin (levofloxacin). On June 13, 2008 a Judicial Panel On Multidistrict Litigation (MDL) granted the Plaintiffs’ motion to centralize individual and class action lawsuits involving Levaquin in the District of Minnesota over objection of defendants, Johnson and Johnson / Ortho McNeil. As a result of this order, product liability attorneys are currently aggressively seeking additional plaintiffs who may have been damaged by this class. Several class action lawsuits had been filed in regards to the adverse reactions suffered by those exposed to ciprofloxacin, another fluoroquinolone drug, during the Anthrax scare of 2001 as well as most recently, a class action lawsuit involving a third fluoroquinolone; Tequin (gatifloxacin). Currently there does not appear to be any class action lawsuits pending that involve pefloxacin, but there are a significant number of law firms aggressively seeking to represent patients who have suffered a spontaneous tendon rupture, or liver injury, following fluoroquinolone therapy.